Cargando…
Five questions that need answering when considering the design of clinical trials
Evidence suggests that research protocols often lack important information on study design, which hinders external review. The study protocol should provide an adequate explanation for why the proposed study methodology is appropriate for the question posed, why the study design is likely to answer...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223595/ https://www.ncbi.nlm.nih.gov/pubmed/25027292 http://dx.doi.org/10.1186/1745-6215-15-286 |
_version_ | 1782343225832374272 |
---|---|
author | Clark, Timothy Davies, Hugh Mansmann, Ulrich |
author_facet | Clark, Timothy Davies, Hugh Mansmann, Ulrich |
author_sort | Clark, Timothy |
collection | PubMed |
description | Evidence suggests that research protocols often lack important information on study design, which hinders external review. The study protocol should provide an adequate explanation for why the proposed study methodology is appropriate for the question posed, why the study design is likely to answer the research question, and why it is the best approach. It is especially important that researchers explain why the treatment difference sought is worthwhile to patients, and they should reference consultations with the public and patient groups and existing literature. Moreover, the study design should be underpinned by a systematic review of the existing evidence, which should be included in the research protocol. The Health Research Authority in collaboration with partners has published guidance entitled ‘Specific questions that need answering when considering the design of clinical trials’. The guidance will help those designing research and those reviewing it to address key issues. |
format | Online Article Text |
id | pubmed-4223595 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42235952014-11-08 Five questions that need answering when considering the design of clinical trials Clark, Timothy Davies, Hugh Mansmann, Ulrich Trials Commentary Evidence suggests that research protocols often lack important information on study design, which hinders external review. The study protocol should provide an adequate explanation for why the proposed study methodology is appropriate for the question posed, why the study design is likely to answer the research question, and why it is the best approach. It is especially important that researchers explain why the treatment difference sought is worthwhile to patients, and they should reference consultations with the public and patient groups and existing literature. Moreover, the study design should be underpinned by a systematic review of the existing evidence, which should be included in the research protocol. The Health Research Authority in collaboration with partners has published guidance entitled ‘Specific questions that need answering when considering the design of clinical trials’. The guidance will help those designing research and those reviewing it to address key issues. BioMed Central 2014-07-16 /pmc/articles/PMC4223595/ /pubmed/25027292 http://dx.doi.org/10.1186/1745-6215-15-286 Text en Copyright © 2014 Clark et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Commentary Clark, Timothy Davies, Hugh Mansmann, Ulrich Five questions that need answering when considering the design of clinical trials |
title | Five questions that need answering when considering the design of clinical trials |
title_full | Five questions that need answering when considering the design of clinical trials |
title_fullStr | Five questions that need answering when considering the design of clinical trials |
title_full_unstemmed | Five questions that need answering when considering the design of clinical trials |
title_short | Five questions that need answering when considering the design of clinical trials |
title_sort | five questions that need answering when considering the design of clinical trials |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223595/ https://www.ncbi.nlm.nih.gov/pubmed/25027292 http://dx.doi.org/10.1186/1745-6215-15-286 |
work_keys_str_mv | AT clarktimothy fivequestionsthatneedansweringwhenconsideringthedesignofclinicaltrials AT davieshugh fivequestionsthatneedansweringwhenconsideringthedesignofclinicaltrials AT mansmannulrich fivequestionsthatneedansweringwhenconsideringthedesignofclinicaltrials |